172 related articles for article (PubMed ID: 25006047)
1. Dual impact of live Staphylococcus aureus on the osteoclast lineage, leading to increased bone resorption.
Trouillet-Assant S; Gallet M; Nauroy P; Rasigade JP; Flammier S; Parroche P; Marvel J; Ferry T; Vandenesch F; Jurdic P; Laurent F
J Infect Dis; 2015 Feb; 211(4):571-81. PubMed ID: 25006047
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL.
Kassem A; Lindholm C; Lerner UH
PLoS One; 2016; 11(6):e0156708. PubMed ID: 27311019
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcal protein A promotes osteoclastogenesis through MAPK signaling during bone infection.
Wang Y; Liu X; Dou C; Cao Z; Liu C; Dong S; Fei J
J Cell Physiol; 2017 Sep; 232(9):2396-2406. PubMed ID: 28185243
[TBL] [Abstract][Full Text] [Related]
4. Human Monocyte-Derived Osteoclasts Are Targeted by Staphylococcal Pore-Forming Toxins and Superantigens.
Flammier S; Rasigade JP; Badiou C; Henry T; Vandenesch F; Laurent F; Trouillet-Assant S
PLoS One; 2016; 11(3):e0150693. PubMed ID: 26934588
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus biofilms decrease osteoblast viability, inhibits osteogenic differentiation, and increases bone resorption in vitro.
Sanchez CJ; Ward CL; Romano DR; Hurtgen BJ; Hardy SK; Woodbury RL; Trevino AV; Rathbone CR; Wenke JC
BMC Musculoskelet Disord; 2013 Jun; 14():187. PubMed ID: 23767824
[TBL] [Abstract][Full Text] [Related]
6. MyD88 and IL-1R signaling drive antibacterial immunity and osteoclast-driven bone loss during Staphylococcus aureus osteomyelitis.
Putnam NE; Fulbright LE; Curry JM; Ford CA; Petronglo JR; Hendrix AS; Cassat JE
PLoS Pathog; 2019 Apr; 15(4):e1007744. PubMed ID: 30978245
[TBL] [Abstract][Full Text] [Related]
7. IgG immune complexes with Staphylococcus aureus protein A enhance osteoclast differentiation and bone resorption by stimulating Fc receptors and TLR2.
Kamohara A; Hirata H; Xu X; Shiraki M; Yamada S; Zhang JQ; Kukita T; Toyonaga K; Hara H; Urano Y; Yamashita Y; Miyamoto H; Kukita A
Int Immunol; 2020 Feb; 32(2):89-104. PubMed ID: 31713625
[TBL] [Abstract][Full Text] [Related]
8. Immune complex-induced inhibition of osteoclastogenesis is mediated via activating but not inhibitory Fcγ receptors on myeloid precursor cells.
Grevers LC; de Vries TJ; Everts V; Verbeek JS; van den Berg WB; van Lent PL
Ann Rheum Dis; 2013 Feb; 72(2):278-85. PubMed ID: 22918932
[TBL] [Abstract][Full Text] [Related]
9. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus capsular material promotes osteoclast formation.
Lau YS; Wang W; Sabokbar A; Simpson H; Nair S; Henderson B; Berendt A; Athanasou NA
Injury; 2006 May; 37 Suppl 2():S41-8. PubMed ID: 16651071
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis.
Josse J; Velard F; Gangloff SC
Front Cell Infect Microbiol; 2015; 5():85. PubMed ID: 26636047
[TBL] [Abstract][Full Text] [Related]
12. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of promoting the differentiation and bone resorption function of osteoclasts by Staphylococcus aureus infection.
Tong Z; Chen Z; Li Z; Xie Z; Zhang H
Int J Med Microbiol; 2022 Oct; 312(7):151568. PubMed ID: 36240531
[TBL] [Abstract][Full Text] [Related]
14. Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through Toll-like receptor 2 with partial involvement of MyD88.
Yang J; Ryu YH; Yun CH; Han SH
J Leukoc Biol; 2009 Oct; 86(4):823-31. PubMed ID: 19602669
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
Martin TJ; Ng KW
J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.
Kohara H; Kitaura H; Fujimura Y; Yoshimatsu M; Morita Y; Eguchi T; Masuyama R; Yoshida N
Immunol Lett; 2011 Jun; 137(1-2):53-61. PubMed ID: 21338623
[TBL] [Abstract][Full Text] [Related]
17. Peptidoglycan and lipopolysaccharide synergistically enhance bone resorption and osteoclastogenesis.
Kishimoto T; Kaneko T; Ukai T; Yokoyama M; Ayon Haro R; Yoshinaga Y; Yoshimura A; Hara Y
J Periodontal Res; 2012 Aug; 47(4):446-54. PubMed ID: 22283724
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus Infects Osteoclasts and Replicates Intracellularly.
Krauss JL; Roper PM; Ballard A; Shih CC; Fitzpatrick JAJ; Cassat JE; Ng PY; Pavlos NJ; Veis DJ
mBio; 2019 Oct; 10(5):. PubMed ID: 31615966
[TBL] [Abstract][Full Text] [Related]
19. Osteoclast culture and resorption assays.
Bradley EW; Oursler MJ
Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
[TBL] [Abstract][Full Text] [Related]
20. Impact of the Maturation of Human Primary Bone-Forming Cells on Their Behavior in Acute or Persistent Staphylococcus aureus Infection Models.
Josse J; Guillaume C; Bour C; Lemaire F; Mongaret C; Draux F; Velard F; Gangloff SC
Front Cell Infect Microbiol; 2016; 6():64. PubMed ID: 27446812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
